Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer

Details for Australian Patent Application No. 2007317859 (hide)

Owner ABRAXIS BIOSCIENCE, LLC

Inventors Soon-Shiong, Patrick; Desai, Neil P.

Agent A J Park

Pub. Number AU-A-2007317859

PCT Pub. Number WO2008/057562

Priority 11/594,417 06.11.06 US

Filing date 6 November 2007

Wipo publication date 15 May 2008

International Classifications

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/057562 Priority application(s): WO2008/057562

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007317872-Pitch and stickies control in pulp and papermaking processes

2007317858-Sprayable, controlled-release, male annihilation technique (MAT) formulation and insect control method